Aurora Cannabis (TSE:ACB) has released an update.
Aurora Cannabis Inc. has received enhanced cultivation and unique research licenses in Germany, bolstering its position in the European medical cannabis market. With these licenses, the company can extend its production and conduct trials on new cultivars, supporting the broader acceptance and accessibility of medical cannabis in Europe.
For further insights into TSE:ACB stock, check out TipRanks’ Stock Analysis page.
